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Some of us remember how to deal with instructions 
as USE, SKIP, GO TOP and GO BOTTOM, especially if 
that comes together with a 286 PC black screen, the 
late 80’s memories and a couple of old 3.5 floppy disks 
named Dbase.
This simple and limited knowledge evolved to a higher 
level when tons of records (volume) merged with velo-
city (to acquire and process it), variety and veracity. The 
aforementioned characteristics (the four “Vs”) define Big 
Data, which was catalyzed by the Internet phenomenon 
that started in 1990s. 
The Big Data concept has captured the attention of 
researchers worldwide as it offers an endless amount 
of patterns and predictions, alarming as much as inte-
resting. Platforms provided a plethora of data, such as 
patient demographics, and clinical, ancillary, and even 
genomic data, which can be helpful for conducting 
large-scale, low-cost healthcare analysis and treatment 
decision-making.
Contemporary democratization included access to 
the “Net,” which brings together major, free databases 
and mathematical models (algorithms) that manipulate 
this information, allowing us to live in an era of artificial 
intelligence.
Contests that challenge young minds in search of 
the best convolutional algorithm (that retrofeeds) using 
open access registers are pictured in movies, such as the 
“The Social Network” from 2010. Moreover, currently, 
being able to code is as important as being able to read 
and write.
We live in a “camera culture” society (named after a 
Massachusetts Institute of Technology media-lab group) 
where there are more cameras than eyes. Where else 
could we extract more features (volume, variety, and 
speed) than medical (veracity) images? Image-related 
subspecialties, such as radiology and ophthalmology, are 
a natural locus to decouple pictures and experiment with 
their colors, contrast, and spatial distribution.
Our major role as clinicians is to classify (veracity) such 
images based on clinical diagnosis and most importantly, 
to find real relevance in the subject.
Several examples of digital classifications are available 
in ophthalmology, such as diabetic retinopathy gradings. 
In such cases, we teach machines how to use human 
impressions and separate retinal image patterns to 
digitally classify them. Continuous feed of categorized 
medical pictures allows the machine to screen cases for 
suspected diseases, thus reducing healthcare costs and 
improving healthcare efficacy.
Surprisingly, an algorithm can take into account huge 
amounts of information that is not important to humans 
and can even separate retinas of men from those of woman, 
which is an impossible task for us(1). Is this artificial in-
telligence? Will we be able to be tutored by machines?
This seems likely, and several correlations and con-
clusions are being drafted at this very moment, offering 
personalized music and movies. This may be the basis 
for personalized medicine that is currently being refer-
red to as “Network Medicine.” Data, tools and artificial 
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intelligence are widely available to create it; however, 
experienced ophthalmologists still are required in this 
process. People who know the method of implementing 
artificial intelligence (even while not being the fastest 
experts in its use) and have daily access to the users 
(persons, community, clinics, and hospitals) add value 
to the solution and can improve practical aplication.
Developments, such as the recent, Preclinical Alzhei-
mer OCT-A findings, will still be described as traditional 
research (“I suspect that the foveal avascular zone is a 
clue to the disease”); however, unexpected conclusions 
may seem magical, scaring us(2). But even scarier are 
the possibilities to manipulate algorithms and produce 
biased conclusions. As scientists and critical clinicians, it 
is our duty to recognize possibilities of data misuse and, 
to be aware of alternatives to avoid that corruption, as 
split learning (https://www.media.mit.edu/publications/ 
split-learning-for-health-distributed-deep-learning-without-
sharing-raw-patient-data/). The world is getting more 
complex, and still much more interesting.
Companies such as “23andMe” have more than 5 million 
users who are genetically screened and experimented 
using gene-based dietary regimens. It is a unique oppor-
tunity to actively participate in the evolution of humanity 
with the application of the natural intelligence. Let us 
give it relevance!
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